凯发·k8国际(中国)首页登录

msl-s1-web

Laboratoria met middelgrote volumes

De betrouwbare oplossingen van Mindray kunnen laboratoria met middelgrote volumes helpen hun workflow te optimaliseren, de effici?ntie te vergroten en een robuuste operatie te handhaven.

Laboratoriumoplossing voor middelgrote volumes

Chemiluminescentie-immunoassay
Chemiluminescentie-immunoassay
De chemiluminescentie-immunoassayoplossingen van Mindray combineren robuuste ontwerpen met de nieuwste geavanceerde technologie?n om te zorgen dat laboratoria van elke omvang betrouwbare en nauwkeurige resultaten kunnen behalen. De hoge kwaliteit van de immunoassay-reagentia van Mindray zorgt voor betrouwbare resultaten met bewezen nauwkeurigheid en prestaties, waardoor minder herhalingstests nodig zijn. Bovendien vereenvoudigt de immunoassay-oplossing van Mindray de bediening en vermindert handmatige tussenkomst voor alle soorten klinische laboratoria.
Hematologie
Hematologie
De hematologieproducten van Mindray zijn bewezen betrouwbare oplossingen op de wereldmarkt geworden. Wij bieden complete oplossingen voor alle laboratoriumgrootten, van klein tot groot. Met innovatieve technologie?n en een focus op hoge kwaliteit, leveren wij betrouwbare en nauwkeurige resultaten om artsen te helpen bij het stellen van nauwkeurige diagnoses. Onze flexibele automatiseringssystemen bieden laboratoriumprofessionals bovendien de mogelijkheid om de optimale oplossing te kiezen voor het verbeteren van hun workflow en verkorten van de doorlooptijd.
Chemie
Chemie
Mindray biedt een verscheidenheid aan schaalbare oplossingen voor klinische chemie om aan de behoeften van verschillende laboratoria te voldoen. Onze chemiesystemen met traceerbaarheid helpen laboratoria om nauwkeurige en vergelijkbare resultaten te verkrijgen. Bovendien kunnen het gebruiksgemak en de geavanceerde workflow de kosteneffici?ntie maximaliseren en de doorlooptijd verbeteren. We bieden ook de mogelijkheid om biochemie met immunoassay te combineren in een geautomatiseerde serumlijn om de productiviteit verder op te voeren.

Resources

HemaBook | Hematologie | Screening op ziekten | Hemabook
Hemabook Chapter 19: Have You Noticed Neutrophil Inclusions in the Thrombocytopenia Smear?
Hemabook | HemaBook
HemaBook Chapter 1 - 18
HemaBook | Hematologie | Hemabook
Hemabook Chapter 18: PLT-H: A new parameter for accurate platelet counting with anti-interference ability
Hematologie | HemaBook | Hemabook
Hemabook Chapter 17: The Clinical Significance of All-in-one CBC Plus ESR Analysis
In the last two chapters, we talked about what ESR is and the applications of ESR, CRP and CBC analysis. ESR is an acute phase reactant and serves as a marker for inflammation. It correlates with disease activity and response to therapy. We understand that single tests are not adequate to confirm any diagnosis, but they do give us important clues.
Hematologie | HemaBook | Hemabook
Hemabook Chapter 16: Where Do You Find Maurer Pigments?
According to the World Health Organization (WHO), there were an estimated 241 million cases of malaria worldwide in 2020, and the estimated number of malaria deaths stood at 627,000 in that year. The African Region was home to 95% of malaria cases and 96% of malaria deaths.
Hematologie | HemaBook | Hemabook
Hemabook Chapter 15: Applications of CBC, ESR and CRP Analysis, Part B
Blood, urine and feces analysis are the three common tests in clinical laboratories. Among them, blood testing is the most important way to keep track of one’s overall physical well-being.
Hematologie | In-vitro diagnostiek | HemaBook | Hemabook | HemaBook
HemaBook Chapter 14: Quick Facts About Erythrocyte Sedimentation Rate (ESR)
The erythrocyte sedimentation rate (ESR), which is determined by the Westergren method, measures how quickly red blood cells (RBCs) settle at the bottom of a blood sample tube in millimeters (mm) in one hour.
Hematologie | Optimal workflow | HemaBook | Hemabook
HemaBook Chapter 13: Capture the Truth About Cell Morphology
Many laboratories are troubled by problems such as lengthy analysis processes and less efficient microscopic examinations due to lacking of experts in cell morphology and inadequate equipment. This makes them hard to reach a 30% overall re-exam rate, a target recommended by the international consensus group for hematology review.
Hematologie | HemaBook | Hemabook
HemaBook Chapter 12: A Clearer Truth? Find it Faster!
In the laboratory, what is the most common reason for you to gather with colleagues to look at and discuss samples or patient results on the screen or in a report?
Hematologie | HemaBook | Hemabook
HemaBook Chapter 11: A 'Sherlock Holmes' Helps You to Capture the Culprit of Diseases
A 43-year-old woman presented with persistent fever for two months. She had visited different hospitals more than three times, but there was no significant improvement in her symptoms. After being admitted to a top-tier hospital in China, she underwent a series of examinations.
Hematologie | HemaBook | Hemabook | COVID-19
Hemabook Chapter 10: How Digital Morphology Systems Help Labs Optimize Their Workflow?
Nowadays, hematology analyzers are used widely in laboratories to automatically count and differentiate blood cells. Nevertheless, blood morphology examination for the presence of abnormal cells is still the ‘gold standard’ in the routine blood count. Microscopic examination is the most valuable procedure in the laboratory, which can suggest some disorders previously identified by the analyzer.
HemaBook | Hemabook | Hematologie | COVID-19
HemaBook Chapter 9: How Does Eosinophil Count Change in COVID-19 Patient
Is prophylactic anticoagulant therapy a common treatment for clinicians to deal with thrombotic events in COVID-19? Is there a connection between the eosinophil count and anticoagulation monitoring in COVID-19 patients?
Hematologie | In-vitro diagnostiek | Hemabook | Laboratoriumdiagnostiek | Laboratoriumdiagnostiek | BC-6800Plus | BC-6800 | BC-6000 | Covid 19 | HemaBook
HemaBook Chapter 8: Have You Noticed the Changes of Red Blood Cells in COVID-19?
As of January 26th, 2021, the coronavirus disease 2019 (COVID-19) pandemic has affected over 100 million people worldwide. Vaccination would help improve the situation in future.
Hematologie | In-vitro diagnostiek | Hemabook | Laboratoriumdiagnostiek | Laboratoriumdiagnostiek | C3100 | C3510 | Covid 19 | HemaBook
HemaBook Chapter 7: How D-dimer in Coagulation Correlates with COVID-19?
As COVID-19 continues to swipe around the world, rapid diagnosis as well as prognosis and treatment of the COVID-19 patients has become an equally important topic among clinicians. Recently scientists have discovered that COVID-19 has a host cell receptor, Angiotensin Converting Enzyme II or ACE2.
Hematologie | In-vitro diagnostiek | Hemabook | Laboratoriumdiagnostiek | Laboratoriumdiagnostiek | HemaBook
HemaBook Chapter 6: Mindray's solution for solving in-vitro PLT aggregation
EDTA-dependent pseudothrombocytopenia (EDTA-PTCP) induced by EDTA anticoagulants is a common laboratory phenomenon. It is caused by in-vitro PLT aggregation and may lead to a low PLT result and, ultimately, misdiagnosis and wrong medical treatment for the patient.
Hematologie | In-vitro diagnostiek | Hemabook | Laboratoriumdiagnostiek | Laboratoriumdiagnostiek | CAL 8000(NIEUW) | CAL 6000 | BC-6800Plus | BC-6200 | BC-6000 | HemaBook
HemaBook Chapter 5: How Mindray Counts Low Platelets Correctly
Derived from megakaryocytes, platelets (PLT) are produced and matured in the bone marrow. Besides widely known thrombosis and wound repair, PLT also plays important roles in inflammation, immunity and cancer biology.
Hematologie | In-vitro diagnostiek | Laboratoriumdiagnostiek | Laboratoriumdiagnostiek | CAL 8000(NIEUW) | CAL 6000 | BC-6800Plus | BC-6200 | BC-6000 | HemaBook | Hemabook
HemaBook Chapter 4: Is Platelet Transfusion Always Required in Thrombocytopenia?
When the platelet (PLT) count is extremely low, is platelet transfusion really required? Let’s analyze the following case, which tells us a different answer.
Hematologie | In-vitro diagnostiek | Laboratoriumdiagnostiek | Laboratoriumdiagnostiek | AACC | CAL 8000(NIEUW) | CAL 6000 | BC-6800Plus | BC-6200 | BC-6000 | HemaBook | Hemabook
HemaBook Chapter 3: Resolve your concerns about the risk of low-value PLT measurements
When the platelet value is low, patients are at risk of bleeding. Bleeding in vital organs is life-threatening. According to Giuseppe Lippi and other professors, there is no universal agreement on the de?nition of platelet transfusion thresholds.
Hematologie | In-vitro diagnostiek | Laboratoriumdiagnostiek | Laboratoriumdiagnostiek | AACC | CAL 8000(NIEUW) | CAL 6000 | BC-6800Plus | BC-6200 | BC-6800 | HemaBook | Hemabook
HemaBook Chapter 2: One More Option to Solve EDTA-PTCP?
Ethylenediaminetetraacetic Acid - Pseudothrombocytopenia (EDTA-PTCP) is a laboratory artifact that may lead to an incorrect evaluation and unnecessary treatment of patients.
Hematologie | In-vitro diagnostiek | Laboratoriumdiagnostiek | Laboratoriumdiagnostiek | AACC | CAL 8000(NIEUW) | CAL 6000 | BC-6800Plus | BC-6200 | BC-6000 | HemaBook | Hemabook
HemaBook Chapter 1: The Stories of Platelet Clump
Thrombocytopenia is a condition characterized by abnormally low levels of platelets in the blood. However, falsely low platelet counts, or pseudothrombocytopenia (PTCP), though easily unrecognized, are found in clinical cases. It is an in vitro phenomenon caused by platelet clumping that results in reporting of a spuriously low platelet count by automatic hematology analyzers.
Meer weergeven